EP Multibagger Stock - March 2026
gift nifty image banner
Want a perfect stocks portfolio for 2026? Create Now
Latest News

Strides Shasun receives USFDA approval for altitude sickness tablets

Strides Shasun’s wholly-owned subsidiary has received green signal from the US health regulator, for Acetazolamide tablets. It is used to prevent and reduce symptoms of altitude sickness.

In a BSE filing the company stated, “Strides Pharma Global Pte. has received approval from the United States Food and Drug Administration (USFDA) for Acetazolamide tablets USP, 125mg and 250 mg.”

Further, the product which has received approval is a generic version of Diamox tablets and it will be marketed by Strides Pharma Inc in the US.

Read EquityPandit’s Technical Analysis on Nifty Pharma

Click here to check market prediction for next trading session.

Get Daily Prediction & Stocks Advise On Your Mobile


I would like to receive communication from EquityPandit via sms, email, whatsapp, Google RCS for offers, updates etc.



Is this the right time to invest?